Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 207, Issue 8, Pages 1757-1773
Publisher
Rockefeller University Press
Online
2010-07-13
DOI
10.1084/jem.20100086
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Excessive Production of IFN- in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B
- (2014) M. Harigai et al. JOURNAL OF IMMUNOLOGY
- Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus–prone B6.Sle1.Yaaanimals
- (2009) Kenichiro Maeda et al. BLOOD
- BAFF: a local and systemic target in autoimmune diseases
- (2009) I. Moisini et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Multiple roles of Lyn kinase in myeloid cell signaling and function
- (2009) Patrizia Scapini et al. IMMUNOLOGICAL REVIEWS
- Autoimmune Disease in Lyn-Deficient Mice Is Dependent on an Inflammatory Environment Established by IL-6
- (2009) E. Tsantikos et al. JOURNAL OF IMMUNOLOGY
- Developmental Acquisition of the Lyn-CD22-SHP-1 Inhibitory Pathway Promotes B Cell Tolerance
- (2009) A. J. Gross et al. JOURNAL OF IMMUNOLOGY
- Interleukin 6 (IL-6) Deficiency Delays Lupus Nephritis in MRL-Faslpr Mice: The IL-6 Pathway as a New Therapeutic Target in Treatment of Autoimmune Kidney Disease in Systemic Lupus Erythematosus
- (2009) H. CASH et al. JOURNAL OF RHEUMATOLOGY
- B-cell-directed therapies for autoimmune disease
- (2009) Thomas Dörner et al. Nature Reviews Rheumatology
- BAFF and the plasticity of peripheral B cell tolerance
- (2008) Jason E Stadanlick et al. CURRENT OPINION IN IMMUNOLOGY
- Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases
- (2008) Changhai Ding EXPERT OPINION ON BIOLOGICAL THERAPY
- BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled?
- (2008) Meera Ramanujam et al. IMMUNOLOGICAL REVIEWS
- B-lymphocyte contributions to human autoimmune disease
- (2008) Koichi Yanaba et al. IMMUNOLOGICAL REVIEWS
- Systemic Lupus Erythematosus
- (2008) Anisur Rahman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis
- (2008) Q. Lai Kwan Lam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact
- (2008) J. L. Scholz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils
- (2007) Patrizia Scapini et al. IMMUNOLOGY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation